AdaptHealth Corp. (NASDAQ:AHCO) Shares Bought by Royce & Associates LP

Royce & Associates LP increased its stake in shares of AdaptHealth Corp. (NASDAQ:AHCO) by 29.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,002,755 shares of the company’s stock after buying an additional 225,350 shares during the quarter. Royce & Associates LP owned about 0.75% of AdaptHealth worth $9,546,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Assetmark Inc. purchased a new stake in shares of AdaptHealth during the fourth quarter worth approximately $28,000. Blue Trust Inc. raised its position in AdaptHealth by 24.1% during the 4th quarter. Blue Trust Inc. now owns 5,746 shares of the company’s stock worth $55,000 after buying an additional 1,115 shares during the last quarter. Quarry LP lifted its stake in shares of AdaptHealth by 4,596.9% in the 3rd quarter. Quarry LP now owns 5,965 shares of the company’s stock worth $67,000 after acquiring an additional 5,838 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management boosted its holdings in shares of AdaptHealth by 15.4% in the fourth quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company’s stock valued at $121,000 after acquiring an additional 1,690 shares in the last quarter. Finally, CIBC Asset Management Inc acquired a new position in shares of AdaptHealth during the third quarter worth about $122,000. Institutional investors and hedge funds own 82.67% of the company’s stock.

Analyst Upgrades and Downgrades

AHCO has been the subject of a number of recent analyst reports. UBS Group lowered their price objective on AdaptHealth from $12.00 to $11.00 and set a “buy” rating on the stock in a report on Thursday, February 13th. Truist Financial upped their price objective on AdaptHealth from $12.00 to $14.00 and gave the stock a “buy” rating in a report on Wednesday, February 26th. Canaccord Genuity Group increased their price objective on AdaptHealth from $13.00 to $14.00 and gave the stock a “buy” rating in a research report on Wednesday, February 26th. Royal Bank of Canada boosted their target price on shares of AdaptHealth from $11.00 to $14.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 26th. Finally, Robert W. Baird increased their price target on shares of AdaptHealth from $14.00 to $16.00 and gave the company an “outperform” rating in a report on Thursday, February 27th. Five equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of $13.80.

AdaptHealth Stock Up 1.4 %

AdaptHealth stock opened at $9.88 on Wednesday. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24. The stock’s fifty day moving average is $10.02 and its two-hundred day moving average is $10.20. AdaptHealth Corp. has a fifty-two week low of $8.35 and a fifty-two week high of $11.90. The firm has a market capitalization of $1.33 billion, a price-to-earnings ratio of -5.99, a price-to-earnings-growth ratio of 1.08 and a beta of 1.30.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.